Bulltick Wealth Management’s BioNTech BNTX Stock Holding History

Bulltick Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,400	Closed	-$361K	–	132
2022 Q4	$361K	Sell	2,400 -60	-2%	-$9.23K	0.1%	93
2022 Q3	$332K	Buy	+2,460	New	+$376K	0.1%	93
2022 Q2	–	Sell	-1,200	Closed	-$205K	–	132
2022 Q1	$205K	Buy	+1,200	New	+$202K	0.05%	130

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Bulltick Wealth Management's BNTX Position: Q1 2023 in Review

Bulltick Wealth Management sold out of BioNTech (BNTX) in Q1 2023, closing a stake of 2,400 shares — an estimated $361K sold.

Bulltick Wealth Management first reported a position in BNTX in Q1 2022 and held it in 3 quarters. The position peaked at $361K in Q4 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q1 2023.

Bulltick Wealth Management reported no remaining BioNTech position as of Q1 2023 after selling out during the quarter.
Bulltick Wealth Management sold 2,400 BioNTech shares in Q1 2023, an estimated $361K.
Bulltick Wealth Management first reported a position in BioNTech in Q1 2022 and held it in 3 quarters.
Bulltick Wealth Management's BioNTech position peaked at $361K in Q4 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q1 2023.

Based on Bulltick Wealth Management's 13F filing for Q1 2023, filed 25 Apr 2024.